infection.' 2 5 Enteropathy associated with graftversus-host reaction (GvHR) in animals and coeliac disease in man are believed to be mediated by activated mucosal T lymphocytes which lead to villous atrophy and crypt hyperplasia.67 Because of immunodeficiency, this mechanism would be impaired in the enteropathy of HIV infection. Thus, it is important to define quantitatively the exact pattern of enteropathy of HIV infection and, in particular, whether there is crypt hyperplasia. Similarly, increases in intraepithelial lymphocytes,8 mucosal mast cells,9 and goblet cells' "1 are associated with T cell mediation, but one study has found that mucosal mast cells were deficient in AIDS. 12 The aim of this study is to apply quantitative histological techniques to assess enteropathy and the number of duodenal mucosal mast cells, intraepithelial lymphocyte and goblet cells in patients with HIV infection and resulting AIDS or AIDS-related complex (ARC).
Methods

SUBJECTS
AIDS or ARC was diagnosed in eight patients by antibody to HIV as determined by an enzyme linked immunosorbent assay which was confirmed by Western blotting, by depletion of CD4 peripheral blood lymphocytes, and by clinical features (Table I) . Seven of eight subjects received zidovudine (AZT) at the time of the Villus area was calculated using a geometric approximation of a small triangle mounted on a larger trapezoid, for which the major base was the maximal basal width (Fig 1) . The surface area was computed by adding the area of this triangle and trapezoid. This method was simplified from a previous algorithm which also used a trapezoid approximation for calculating villus area, as described by Lorenz-Meyer, Kohn and Riecken.'4 Their alogrithm, which was validated planimetrically, calculates the surface area of both surfaces of the villus, whereas the present one calculates the surface area of one face. We have used data from another study by these authors in the rat,'' and shown a correlation (r2) of 0-95 by the two methods. Surface area was calculated using a computer program written for the Apple Macintosh computer. This impaired crypt hyperplasia should be regarded as relative because crypt length was similar to those of normal subjects rather than being hypoplastic. This could be because of the influence of residual T cells, or because of nonimmune factors also influencing the proliferation of intestinal crypts. The similarity in intestinal crypt length of HIV-infected and control subjects would indicate equivalent crypt cell population as crypt length and crypt cell count are directly correlated. The discrepancy between this and some (but impaired) increase to mitotic activity suggests that there was crypt cell destruction due to HIV infection, as otherwise crypt length would be increased in HIV subjects. This notion has some support by the finding of HIV infection in intestinal and rectal crypts in an in situ -hybridisation study.2' This would mean there is decreased crypt cell efflux onto villi of HIV-infected subjects from reduced mitotic rate as well as from destruction of crypt cells within the intestinal crypt.
The relative failure of crypt hyperplasia contrasts with the study by Kotler et al.S which reported crypt hyperplasia in biopsies of small intestine from AIDS patients. Their study was based on subjective assessment without quantitative measures because of acknowledged difficulties with imperfect orientation of biopsies. The use of a microdissection technique in our study has overcome this problem. It is also possible that their study may have had individuals who were not as immunodeficient as those in our present study and whose biopsy might have therefore shown some measure of crypt hyperplasia. Batman et al24 also reported crypt hyperplastic villous atrophy in quantitative study of enteropathy of HIV infection. They measured the mucosal architecture index that is, the ratio of surface area to volume of lamina propria, and column count of the intestinal crypt. A lower architecture index confirmed villous atrophy in HIV subjects, particularly those with AIDS. The authors concluded that crypt length by column cell count in HIV subjects had a tendency to crypt hyperplasia, although their data overlapped with that of control subjects, as was the case for four of their AIDS individuals. No statistics were done to reach this conclusion for this particular measurement, and no comparison was made of crypt length in a disease group known to have crypt hyperplasia such as coeliac disease.
Irani et al'2 found that mucosal mast cells ('T mast cell') in the ileum of three patients with AIDS were reduced to 5% of the number in normal ileam, and similarly that mucosal mast cells were reduced (to less than 1%) in two patients with severe combined immunodeficiency syndrome. The majority of these specimens were taken at autopsy, and thus it is likely that these agonal patients were severely malnourished. This could be a confounding factor for the reduction of mucosal mast cell as malnutrition in the rat depletes mucosal mast cells, although, interestingly, it has less of an effect on functional mucosal mast cell activity. 
